5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N Struktur
CAS-Nr.
Englisch Name:
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N
Synonyma:
AICAR-13C2,15N;Arasine-13C2,15N;GP 1-110-13C2,15N;Acadesine-13C2,15N;NSC 105823-13C2,15N;5-AMino-4-iMidazolecarboxaMide Riboside-13C2,15N;5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N
CBNumber:
CB42507734
Summenformel:
C9H14N4O5
Molgewicht:
258.23126
MOL-Datei:
Mol file

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N Eigenschaften

Schmelzpunkt:
187-192°C
storage temp. 
-20°C Freezer
Löslichkeit
DMSO (Very Slightly, Heated), Methanol (Very Slightly, Heated)
Aggregatzustand
Solid
Farbe
White to Light Red

Sicherheit

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White Solid

Verwenden

A labelled nucleoside analogue that is able to enter nucleoside pools and is able to significantly increase levels of adenosine during periods of ATP breakdown. Adenosine-regulating agents (ARAs) hav e been recognized for therapeutic potential in myocardial ischemia. Cardioprotective.

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50

  • NSC 105823-13C2,15N
  • 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N
  • 5-AMino-4-iMidazolecarboxaMide Riboside-13C2,15N
  • Acadesine-13C2,15N
  • AICAR-13C2,15N
  • Arasine-13C2,15N
  • GP 1-110-13C2,15N
  • C713C2H14N315NO5
  • Bases & Related Reagents
  • Carbohydrates & Derivatives
  • Isotope Labelled Compounds
  • Nucleotides
Copyright 2019 © ChemicalBook. All rights reserved